Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues
March 29th, 2021
2.2K views
Digital annotation with automated tissue dissection provides an innovative approach to enriching tumor in low tumor content cases and is adaptable to both paraffin and frozen tissue types. The described workflow improves accuracy, reproducibility and throughput and could be applied to both research and clinical settings.
Overview
This article presents a protocol for automated tissue dissection to enrich tumor regions from low tumor content tissues, facilitating high-quality nucleic acid extraction for downstream applications such as whole exome sequencing. The method leverages digital annotation overlays on unstained slides, improving accuracy, reproducibility, and throughput compared to traditional macro-dissection and laser capture microdissection.
Key Study Components
Area of Science
- Molecular pathology
- Tissue dissection technology
- Genomic analysis
Background
- Low tumor content tissues (<20% tumor) often yield insufficient material for reliable downstream assays.
- Traditional macro-dissection is user-dependent and imprecise, while laser capture microdissection is time-consuming and costly.
- Automated tissue dissection offers a solution by combining digital annotation with precise, automated milling.
- Accurate enrichment of tumor regions is critical for clinical and research sequencing workflows.
Purpose of Study
- To demonstrate a protocol for automated enrichment of tumor regions in FFPE or fresh frozen tissues.
- To improve the efficiency and reproducibility of tissue dissection for nucleic acid extraction.
- To enable high-quality data generation from low tumor content samples for sequencing applications.
Methods Used
- Digital annotation of tumor regions on scanned H&E-stained reference slides using specialized or open-source software.
- Overlay of digital annotations onto unstained tissue slides for precise targeting.
- Automated milling of annotated regions using a 250 µm2 diameter blade on FFPE or fresh frozen sections up to 20 µm thick.
- Collection of dissected tissue for nucleic acid extraction and subsequent whole exome sequencing.
Main Results
- Automated dissection efficiently isolates small, dispersed tumor regions from low tumor content tissues.
- Post-dissection H&E staining confirms accurate removal of annotated regions.
- Collection metrics demonstrate successful enrichment and nucleic acid extraction.
- The protocol increases throughput and reduces slide usage compared to manual methods.
Conclusions
- Automated tissue dissection enhances accuracy and reproducibility in tumor enrichment from low-content samples.
- The method bridges the gap between macro-dissection and laser capture microdissection.
- It is suitable for both clinical and research applications requiring high-quality nucleic acid for sequencing.
Frequently Asked Questions
What types of tissues can be processed with this automated dissection protocol?
The protocol is compatible with both formalin-fixed paraffin-embedded (FFPE) and fresh frozen tissue sections from animal or human sources.
How are tumor regions identified for dissection?
Tumor regions are annotated digitally on scanned H&E-stained reference slides, which are then overlaid onto unstained tissue slides for precise targeting during dissection.
What is the minimum tumor content suitable for this method?
The method is specifically designed for low tumor content tissues, typically those with less than 20% tumor content.
How does automated dissection compare to traditional methods?
Automated dissection reduces user-dependent variability, increases throughput, and requires less time and expertise compared to macro-dissection and laser capture microdissection.
What downstream applications are enabled by this protocol?
The enriched tissue is suitable for nucleic acid extraction and downstream applications such as whole exome sequencing and other genomic analyses.
How is the accuracy of dissection confirmed?
Post-dissection H&E staining of sample slides is used to confirm that the annotated regions have been accurately removed.
Can this protocol be adapted for regions of interest other than tumors?
Yes, the protocol can be used to enrich any region of interest in tissue sections to improve adequacy for sequencing or other analyses.
Executive Industry Relevance
Automated dissection for tumor enrichment in low tumor content tissues addresses a critical bottleneck in generating high-quality nucleic acid for downstream genomic assays. By reducing user-dependent variability and increasing throughput, this protocol enhances predictive confidence and reproducibility at the interface of discovery and translational research. Its integration supports risk-adjusted decision-making and portfolio advancement in oncology-focused R&D pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables precise isolation of tumor regions, supporting robust target validation in heterogeneous tissue samples.
- Reduces biological ambiguity by improving the purity of input material for molecular analyses.
- Facilitates confident hypothesis testing by minimizing contamination from non-tumor tissue.
Screening & Assay Development
- Prepares enriched samples suitable for standardized downstream assays such as next generation sequencing.
- Improves assay reproducibility by automating tissue selection and dissection steps.
- Supports scalable workflows by increasing throughput and reducing slide usage.
Translational & Preclinical Research
- Aligns sample preparation with requirements for translational biomarker discovery and validation.
- Ensures continuity from tissue acquisition to genomic data generation in preclinical models.
- De-risks translational studies by providing high-quality, tumor-enriched nucleic acid inputs.
Pipeline & Workflow Integration
This automated dissection protocol fits between tissue acquisition and nucleic acid extraction, enabling reliable sample preparation for sequencing and molecular profiling in both discovery and translational workflows.
- Discovery Biology: Supports hypothesis-driven studies by enabling accurate region-of-interest isolation from complex tissues.
- Screening: Delivers reproducible, quantitative enrichment suitable for high-throughput sequencing assays.
- Analytics: Provides collection metrics and post-harvest confirmation to validate sample quality and enrichment success.
- Translational Research: Bridges preclinical and clinical sample processing with standardized, scalable enrichment methods.
- Enterprise Reuse: Offers a platform-agnostic capability adaptable to various tissue types and research questions.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in molecular analyses.
- Operational Value: Standardizes tissue enrichment, improving reproducibility and throughput.
- Strategic Value: Enables more informed go/no-go decisions by ensuring high-quality input for downstream assays.
- Portfolio Impact: Supports risk-adjusted prioritization by reducing sample-related variability in genomic studies.
Implementation Considerations
- Requires expertise in digital pathology annotation and automated dissection software operation.
- Needs access to compatible imaging, annotation, and milling instrumentation.
- Demands cross-team standardization of annotation and dissection parameters for reproducibility.
- Adaptable to both FFPE and fresh frozen tissues from animal or human sources.
- Dependent on accurate overlay and alignment of digital annotations for optimal enrichment.
Biopharma FAQs
Why does null hypothesis testing matter for tumor region annotation?
Null hypothesis testing ensures that observed differences in downstream sequencing data are attributable to true biological variation, not sampling bias from imprecise tumor region annotation. This statistical rigor underpins target validation and reduces the risk of false positives in discovery workflows.
How does independent variable isolation fit automated tissue dissection?
Automated dissection enables isolation of tumor regions as independent variables, minimizing confounding from adjacent non-tumor tissue. This precision supports mechanistic studies and increases confidence in downstream molecular readouts.
What do quantitative dependent variable measurements enable in this protocol?
Quantitative metrics such as area dissected and nucleic acid yield provide objective measures of enrichment success, supporting reproducibility and enabling cross-sample comparisons in sequencing-based assays.
Why are replication requirements critical for cross-functional tissue enrichment?
Replication ensures that automated dissection produces consistent enrichment across multiple samples and operators, facilitating reliable data generation for collaborative translational and discovery teams.
Which statistical analysis capabilities are required before implementing automated dissection?
Teams must be able to analyze pre- and post-harvest metrics, confirm enrichment accuracy via post-dissection staining, and assess nucleic acid quality to validate the protocol's impact on downstream assay performance.
